文献速递胃肠外科肝胆胰外科

微创单一体位左胸食管裂孔入路与腹腔镜经食管裂孔入路治疗Siewert II型食管胃结合部腺癌的比较

Comparison of minimally invasive single-position left transthoracic and esophageal hiatal approach versus laparoscopic transesophageal hiatus approach for Siewert type II adenocarcinoma of the esophagogastric junction.
PubMed 文献 · Surg Endosc · 2026-06-17

该回顾性研究分析了196例Siewert II型食管胃结合部腺癌患者,比较微创单一体位左胸食管裂孔入路(SLTEA组106例)与腹腔镜经食管裂孔入路(LTHA组90例)的围手术期指标和术后生存率。结果显示SLTEA组手术时间、术后首次下床时间、首次肠蠕动时间和术后住院时间更短,近端食管切缘更长,淋巴结清扫总数更多,5年总生存率更高(P=0.0386)。结论认为SLTEA安全有效,可作为Siewert II型AEG手术的补充选择。

要点

  • SLTEA组手术时间、术后恢复指标及住院时间均短于LTHA组(P<0.001)。
  • SLTEA组近端食管切缘更长、淋巴结清扫总数更多(P<0.001)。
  • SLTEA组5年总生存率高于LTHA组(P=0.0386)。

核心结论

  • 对于Siewert II型AEG患者,微创SLTEA安全有效,手术时间更短、食管切缘更长、淋巴结清扫更彻底、术后恢复更好,且有利于长期生存。
  • SLTEA可作为Siewert II型AEG手术的补充选择进行推广。

研究设计与样本

  • 按手术入路分为SLTEA组(n=106)和LTHA组(n=90),比较临床资料、围手术期指标和术后生存率。

主要发现

  • SLTEA组手术时间、术后首次下床时间、术后首次肠蠕动时间及术后住院时间均短于LTHA组(P<0.001)。
  • SLTEA组近端食管切缘长度长于LTHA组,淋巴结清扫总数多于LTHA组(P<0.001)。
  • K-M生存曲线显示SLTEA组5年总生存率高于LTHA组(P=0.0386)。

临床怎么用

  • 对于Siewert II型AEG,可考虑采用微创单一体位左胸食管裂孔入路,以缩短手术时间、保证食管切缘和淋巴结清扫。
  • 该入路可能改善术后恢复和长期生存,可作为腹腔镜经食管裂孔入路的补充选择。

局限性

  • 回顾性研究,非随机分组,可能存在选择偏倚。
  • 单中心、同一手术团队数据,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the validity and feasibility of a minimally invasive single-position left transthoracic and esophageal hiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction. METHODS: Clinical data of 196 patients with Siewert type II AEG treated by the same surgical team from January 2017 to December 2019 at our institution were retrospectively analyzed. Patients were categorized into the minimally invasive single-position left transthoracic and esophageal hiatal approach (SLTEA) group (n = 106) and the minimally invasive laparoscopic transesophageal hiatus approach (LTHA) group (n = 90) according to the surgical approach, and the clinical data, perioperative indices, and postoperative survival rates of the two groups were compared. RESULTS: The SLTEA group had shorter surgical time, first ambulation time after surgery, first postoperative intestinal peristalsis time, and postoperative hospital stay than the LTHA group (P < 0.001). Besides, the SLTEA group had longer proximal esophageal cut edge length and a higher total number of lymph node dissections than the LTHA group (P < 0.001). The K-M survival curve shows that the five-year overall survival rate of the SLTEA group is higher than that of the LTHA group (P = 0.0386). CONCLUSION: For patients with Siewert type II AEG, the minimally invasive SLTEA is safe and effective, with shorter operative time, longer esophageal margins, more complete lymph node dissection, better postoperative recovery, and more benefits for patients' long-term survival. It can be promoted as a complementary option to Siewert type II AEG surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wei H, Wang M, Xu N, et al. Comparison of minimally invasive single-position left transthoracic and esophageal hiatal approach versus laparoscopic transesophageal hiatus approach for Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc. 2026. PMID: 42310199. doi:10.1007/s00464-026-12981-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。